Skip to main content

Craniomaxillofacial Devices Market to Grow at 6.8% CAGR Driven by Rising Procedures by 2030

 

The global CMF (Craniomaxillofacial) Devices Market estimated at $2.2 billion (2022), is growing at a CAGR of 6.8%. The craniomaxillofacial devices market growth is driven by an increasing volumes of CMF procedures and the growing adoption of patient specific implants.

CMF devices are used during surgeries to treat injuries, defects, and diseases in the head, neck, face, jaws, hard and soft tissues of the cranial and maxillofacial region. The CMF devices market consists of implants, software, anatomic models, instruments, and surgical guides.

Download a free sample report now 👉
https://meditechinsights.com/cmf-craniomaxillofacial-devices-market/request-sample/

High incidence of traumatic brain injuries (TBIs) is driving the demand for CMF devices

Head injuries are one of the most common causes of disability and death in adults. According to the Journal of Neurosurgery, 69 million individuals across the globe are estimated to sustain a TBI each year. About 2.8 million TBIs occur in the U.S. every year (Source: CDC). Large number of TBIs and associated skull fractures are driving the demand for CMF devices.

Sports related injuries are propelling the volumes of CMF procedures

The growth in the number of injuries caused due to sports activities is expected to increase the demand for CMF devices. According to John Hopkins Medicine, over 3.5 million sports-related injuries are reported every year in the U.S and almost one-third of all injuries incurred in childhood are sports-related injuries.

Growing demand for patient specific implants (PSIs)

The CMF devices market is dominated by standard/off-the-shelf implants. However, the demand for patient-specific implants is growing. This is attributed to the advances in imaging techniques that allow physicians to recreate a computerized model of the patient's anatomy and provide personalized solutions. Further, improvements in the CMF planning software have added tools that help surgeons make almost any measurement possible and align the bone segments in a perfectly symmetrical manner. This has enabled designing patient specific solutions with high accuracy.

Point of Care (POC) 3D Printing to offer growth opportunities in Craniomaxillofacial Devices Market

Point of care (POC) 3D printing is likely to find greater traction in the coming years. Hospitals are increasingly looking for POC 3D printing solutions owing to its benefits like direct communication between engineer and the surgeon and accelerated delivery. Key players such as KLS Martin have already began to focus on POC services. Recently, Charite hospital (Germany) entered into a public-private partnership with KLS Martin. They shared investment for the printers in hospitals and KLS is printing the implants for Charite.

North America leads the adoption of Craniomaxillofacial Devices Market

From a geographic perspective, North America has a major market share of global CMF devices market. This is mainly attributed to the large volumes of CMF procedures, high incidence of trauma injuries, relatively greater penetration and reimbursement of CMF products in the region.

Download a sample report for in-depth competitive insights
https://meditechinsights.com/cmf-craniomaxillofacial-devices-market/request-sample/

Competitive Landscape Analysis: Craniomaxillofacial Devices Market

Some of the key players operating in the global CMF devices market include KLS Martin, DePuy Synthes Companies (JnJ), Stryker, Medartis, Renishaw, Zimmer Biomet, Medtronic, Materialise, Xilloc Medical, Synimed, Medicon, 3D Systems, 3D Life Prints, Nutechnologies, 3Di, among others.

Companies adopting organic growth strategies to increase their market share

As a key growth strategy, companies in the Craniomaxillofacial Devices market are focusing on strategic expansions. For instance,

  • In 2021, KLS Martin opened the new production building "Building 70" in Mühlheim, Germany. In the U.S. the company expanded its production building. Further, a new, larger office with a showroom was inaugurated in Shanghai, China.
  • In March 2020, KLS Martin opened a new planning office for Individual Patient Solutions (IPS) in Cardiff, U.K. to bring a more personal and local service to UK clinicians.

In January 2019, DePuy Synthes invested €36 million in expanding R&D capabilities at its Ireland Innovation Center. The investment would help a five-year project focusing on advancing material science in 3D printing, coatings and surface treatments for high quality implants and medical devices. The investment also aimed an establishment of a 3D Printing Development and Launch Center.

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more